People with long COVID have distinct differences in the mix of bacteria that live in their mouths and lungs, according to a study of more than 700 people published in the European Respiratory Journal. The research also shows that these differences in the lung microbiome are linked to respiratory symptoms, as well as the cognitive and digestive problems known to occur in long COVID.
❓ Unknown
Distinct Lung and Mouth Microbiome Differences Linked to Severe Long COVID Symptoms
2w ago
October 12, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
A study published in the European Respiratory Journal reveals that individuals with long COVID exhibit significant differences in the microbiomes of their lungs and mouths, which correlate with respiratory, cognitive, and digestive symptoms. This research involves over 700 participants and highlights the ongoing health challenges posed by long COVID. Understanding these health issues is crucial for Iran, as they may impact public health policy and resource allocation.
🔍 Quick Context Guide
💡 Bottom Line:
The research underscores the importance of microbiome differences in managing long COVID symptoms.
👥 Key Players
European Respiratory Journal
MENTIONED
Academic publication
"Credible source for research findings that can influence health policies and practices."
Researchers involved in the study
MENTIONED
Scientists conducting the microbiome research
"Their findings contribute to understanding long COVID, which is crucial for public health responses."
📰 What Happened
A study published in the European Respiratory Journal found that individuals with long COVID have distinct differences in their lung and mouth microbiomes, which are linked to various symptoms. The research involved over 700 participants and highlights the ongoing health challenges associated with long COVID.
- The study analyzed microbiome differences in over 700 individuals with long COVID.
- Distinct differences in microbiomes were associated with respiratory, cognitive, and digestive symptoms.
💡 Why It Matters
🇮🇷 For Iran: Understanding the microbiome's role in long COVID can help Iranian health authorities develop targeted interventions and allocate resources effectively.
🌍 Regional: Long COVID is a global issue, and insights from this research could influence regional health strategies.
🌐 International: The study contributes to the global understanding of long COVID, which is relevant for international health policies and research funding.
📚 Background
Long COVID refers to a range of symptoms that persist after the acute phase of COVID-19, affecting many individuals worldwide. Research into its causes and effects is critical for effective treatment and management.
COVID-19
Public health policy
📡 Source:
NEUTRAL
📊 Confidence:
70%
The European Respiratory Journal is a reputable source for peer-reviewed research, making it a reliable reference for health-related studies.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
5 min ago •
Educational Justice and Growth: Key Elements of the Supreme Leader's Message at the Start of…
5 min ago •
Vehicle Traffic is the Main Cause of Air Pollution in Qom During Winter
7 min ago •
Iran Submits Evidence of US-Israeli Attacks on Maritime Infrastructure to IMO
8 min ago •
Conversion of Worn Tires and Tree Branches into Usable Materials in Shiraz
8 min ago •